The fate of chemoresistance in triple negative breast cancer (TNBC)
2015 · BBA Clinical · 371 citations
https://doi.org/10.1016/j.bbacli.2015.03.003
R
Riona Tully
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
8
Papers
874
Citations
6
h-index
6
i10-index
Riona Tully is an academic researcher. The author has contributed to research in topics: COVID-19 Clinical Research Studies & Sepsis Diagnosis and Treatment & Long-Term Effects of COVID-19. The author has an h-index of 6, co-authored 7 publications.
Papers by this author
worksEffect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19
2022 · JAMA · 149 citations
https://doi.org/10.1001/jama.2022.2910
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
2022 · JAMA · 134 citations
https://doi.org/10.1001/jama.2022.23257
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
2021 · Intensive Care Medicine · 96 citations
https://doi.org/10.1007/s00134-021-06448-5
Intravenous Vitamin C for Patients Hospitalized With COVID-19
2023 · JAMA · 45 citations
https://doi.org/10.1001/jama.2023.21407
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat